Steve Duffy

Digital Content Editor

All articles by Steve Duffy

Guselkumab Superior to Secukinumab in Plaque Psoriasis Trial

According to results from the ECLIPSE trial, treatment with guselkumab was found to be superior to secukinumab in adult patients with moderate-to-severe plaque psoriasis based on 90% or better improvement in patients’ Psoriasis Area and Severity Index score compared to baseline (PASI 90 response).

Next post in Dermatitis